Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation
High-risk neuroblastoma is one of the most common deaths in pediatric oncology. Current treatment of this disease involves a coordinated sequence of chemotherapy, surgery, and radiation. Further advances in therapy will require the targeting of tumor cells in a more selective and efficient way so th...
Main Authors: | Ching-An Peng, Chung-Hao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/1/227/ |
Similar Items
-
Synthesis and Characterization of Gold Nanorods and Their Application for Photothermal Cell Damage [Retraction]
by: Samim M, et al.
Published: (2022-10-01) -
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2
by: Cristina Larrosa, et al.
Published: (2023-07-01) -
Novel Gold Nanorods@Thiolated Pectin on the Killing of HeLa Cells by Photothermal Ablation
by: Osvaldo Beltran, et al.
Published: (2023-11-01) -
Laser thermal therapy is increasingly being used in clinical practice for cancer treatment. Its major limitation is associated with low spatial selectivity. This restriction may be excluded by the use of plasmon-resonant gold nanoparticles as photothermal
by: Chumakov D.S., et al.
Published: (2013-12-01) -
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
by: Juan Pablo Muñoz, et al.
Published: (2023-10-01)